secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVELATION BIOSCIENCES, INC. (REVB)
CIK:        0001810560
Form:       8-K
Filed at:   2025-01-30T23:59:59+00:00
Accession:  0000950170-25-011197
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Revelation Biosciences effects 1-for-16 reverse stock split; shares outstanding cut to ~522K
--------------------------------------------------------------------------------

- Reverse stock split effective Jan 28, 2025, at 1-for-16 ratio; no fractional shares issued.
- Approximately 522,281 shares of common stock outstanding after the split.
- Proportionate adjustments made to all outstanding equity awards and warrants, except certain warrants with price reset features.
- Common stock continues to trade under symbol REVB on Nasdaq; new CUSIP 76135L606.
- Split approved by stockholders at Jan 17, 2025 special meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810560/000095017025011197/0000950170-25-011197-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810560/000095017025011197/revb-20250128.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-011197

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer